152 related articles for article (PubMed ID: 37301371)
1. Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin score.
Ooi H; Asai Y; Sato Y
J Infect Chemother; 2023 Sep; 29(9):900-904. PubMed ID: 37301371
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ceftriaxone Dosage and Albumin-Bilirubin Score on the Risk of Ceftriaxone-Induced Liver Injury.
Ooi H; Asai Y; Koriyama Y; Takahashi M
Biol Pharm Bull; 2023; 46(12):1731-1736. PubMed ID: 38044131
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory and clinical studies of sulbactam/ampicillin in pediatric field].
Nishimura T; Tabuki K; Aoki S; Sugita K; Takagi M
Jpn J Antibiot; 1989 Mar; 42(3):687-700. PubMed ID: 2746849
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
[TBL] [Abstract][Full Text] [Related]
5. [Studies on sulbactam/ampicillin in the field of pediatrics].
Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of sulbactam/ampicillin in children].
Ito S; Mayumi M; Ito M; Mikawa H
Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics].
Sato Y; Ishikawa K; Iwata S; Akita H; Oikawa T; Sunakawa K
Jpn J Antibiot; 1989 Mar; 42(3):579-93. PubMed ID: 2746843
[TBL] [Abstract][Full Text] [Related]
8. [Sulbactam/ampicillin-induced pneumonitis].
Miyashita N; Nakajima M; Kuroki M; Kawabata S; Hashiguchi K; Niki Y; Kawane H; Matsushima T
Nihon Kokyuki Gakkai Zasshi; 1998 Aug; 36(8):684-9. PubMed ID: 9844387
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].
Hattori K; Higashino H; Kobayashi T; Yamamoto C; Nobori U; Nakamura Y; Satou Y; Kurokawa H; Nogi S; Kobayashi Y
Jpn J Antibiot; 1989 Mar; 42(3):701-17. PubMed ID: 2746850
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Ishibashi T; Harada Y; Takamoto M; Ebihara M; Sugiyama M; Shimazu K; Iwanaga T; Kishikawa R; Makie T; Tsurutani H; Kisanuki K; Mitsuno T; Hirota N; Furuno T; Hiraoka T; Tsumori Y; Matsuura Y; Namba K; Oe T; Inuyama M; Chifu S; Fukunaga H; Ueno Y; Matsukizono K; Genka K
Jpn J Antibiot; 1998 Dec; 51(12):746-58. PubMed ID: 10077773
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].
Yanagishima M; Yanai M; Yanagi T; Tsuji Y; Nakayama N; Imamura H
Jpn J Antibiot; 1989 Mar; 42(3):754-65. PubMed ID: 2746855
[TBL] [Abstract][Full Text] [Related]
12. Comparison of safety between high and low doses of sulbactam/ampicillin: A retrospective observational study in Japanese patients with pneumonia.
Imanishi K; Nakakura I; Miyabe T; Sako R; Yamauchi K
J Infect Chemother; 2020 Nov; 26(11):1152-1157. PubMed ID: 32622622
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
[TBL] [Abstract][Full Text] [Related]
15. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic and clinical studies of sultamicillin granule in the pediatric field].
Motohiro T; Sakata Y; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Yamashita F; Takajo N
Jpn J Antibiot; 1988 Dec; 41(12):1980-2000. PubMed ID: 3249372
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study.
Takahara S; Tokura T; Nishida R; Uefuji A; Ichimura K; Nishihara H; Aoki K; Takayama H; Nakagawa N; Harada T
Injury; 2022 Apr; 53(4):1517-1522. PubMed ID: 35090733
[TBL] [Abstract][Full Text] [Related]
18. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].
Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
Jpn J Antibiot; 1989 Mar; 42(3):623-38. PubMed ID: 2746846
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrospinal fluid levels of sulbactam/ampicillin in rabbits with staphylococcal meningitis].
Haruta T; Okura K; Kuroki S; Yamamoto H; Kobayashi Y
Jpn J Antibiot; 1989 Mar; 42(3):594-7. PubMed ID: 2746844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
